###begin article-title 0
###xml 31 32 28 29 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
IgG Autoantibodies against beta2-Glycoprotein I Complexed with a Lipid Ligand Derived from Oxidized Low-Density Lipoprotein are Associated with Arterial Thrombosis in Antiphospholipid Syndrome
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 22 36 22 36 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML">J. Lipid Res. </italic>
###xml 36 38 36 38 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">42</bold>
###xml 52 54 52 54 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">43</bold>
###xml 69 71 69 71 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML">44</bold>
###xml 94 95 91 92 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 116 117 110 111 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 301 302 292 293 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 357 358 345 346 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 496 497 481 482 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 778 779 760 761 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1106 1107 1085 1086 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1158 1159 1134 1135 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1322 1323 1295 1296 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 478 486 <span type="species:ncbi:9606">patients</span>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 698 706 <span type="species:ncbi:9606">patients</span>
###xml 918 926 <span type="species:ncbi:9606">patients</span>
###xml 989 997 <span type="species:ncbi:9606">patients</span>
###xml 1126 1134 <span type="species:ncbi:9606">patients</span>
We recently reported [J. Lipid Res. 42 (2001), 697; 43 (2002), 1486; 44 (2003), 716] that beta2-glycoprotein I (beta2GPI) forms complexes with oxidized LDL (oxLDL) and autoantibodies against these complexes are present in patients with SLE and antiphospholipid syndrome (APS). The relationship of beta2GPI/oxLDL complexes and IgG autoantibodies against beta2GPI complexed with oxLig-1 (an oxLDL-derived ligand) with clinical manifestations of APS was studied in 150 APS and SLE patients. The beta2GPI/oxLDL levels of APS patients were similar to those of SLE patients without APS, but they were significantly higher than healthy individuals. There was no difference in the complex levels among the patients with arterial, venous thrombosis, or pregnancy morbidity. IgG anti-beta2GPI/oxLig-1 levels of APS were significantly higher than those of SLE without APS and healthy individuals. Further, antibody levels of APS patients with arterial thrombosis were significantly higher than those patients with venous thrombosis and pregnancy morbidity. Thus, oxidation of LDL leads the complex formation with beta2GPI in SLE and APS patients. In contrast, anti-beta2GPI/oxLig-1 autoantibodies were generated only in APS and were strongly associated with arterial thrombosis. These results suggest that autoantibodies against beta2GPI/oxLDL complexes are etiologically important in the development of atherosclerosis in APS.
###end p 2

